[1]
G. N. Marta, M. S. Mano, e A. A. L. Pereira, “ANALYSIS OF CLINICAL OUTCOMES BASED ON MOLECULAR SUBTYPES IN PATIENTS WITH BREAST CANCER THAT RECEIVED NEOADJUVANT CHEMOTHERAPY”, MAST, vol. 29, nº 3, p. 4, set. 2019.